ProShare Advisors’s Evolent Health EVH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Sell |
24,066
-925
| -4% | -$10.4K | ﹤0.01% | 1518 |
|
|
2025
Q1 | $237K | Sell |
24,991
-7,522
| -23% | -$71.2K | ﹤0.01% | 1571 |
|
|
2024
Q4 | $366K | Buy |
32,513
+10,698
| +49% | +$120K | ﹤0.01% | 1482 |
|
|
2024
Q3 | $617K | Buy |
21,815
+6,758
| +45% | +$191K | ﹤0.01% | 1016 |
|
|
2024
Q2 | $288K | Sell |
15,057
-5,141
| -25% | -$98.3K | ﹤0.01% | 1316 |
|
|
2024
Q1 | $662K | Buy |
20,198
+1,962
| +11% | +$64.3K | ﹤0.01% | 937 |
|
|
2023
Q4 | $602K | Buy |
18,236
+3,924
| +27% | +$130K | ﹤0.01% | 936 |
|
|
2023
Q3 | $390K | Sell |
14,312
-17
| -0.1% | -$463 | ﹤0.01% | 1049 |
|
|
2023
Q2 | $434K | Buy |
14,329
+4,680
| +49% | +$142K | ﹤0.01% | 1034 |
|
|
2023
Q1 | $313K | Sell |
9,649
-900
| -9% | -$29.2K | ﹤0.01% | 1191 |
|
|
2022
Q4 | $296K | Buy |
10,549
+1,512
| +17% | +$42.5K | ﹤0.01% | 1240 |
|
|
2022
Q3 | $324K | Sell |
9,037
-172
| -2% | -$6.17K | ﹤0.01% | 1104 |
|
|
2022
Q2 | $283K | Sell |
9,209
-5,746
| -38% | -$177K | ﹤0.01% | 1247 |
|
|
2022
Q1 | $483K | Sell |
14,955
-2,458
| -14% | -$79.4K | ﹤0.01% | 1296 |
|
|
2021
Q4 | $481K | Buy |
17,413
+7,480
| +75% | +$207K | ﹤0.01% | 1478 |
|
|
2021
Q3 | $308K | Sell |
9,933
-10,177
| -51% | -$316K | ﹤0.01% | 1525 |
|
|
2021
Q2 | $425K | Sell |
20,110
-66
| -0.3% | -$1.4K | ﹤0.01% | 1646 |
|
|
2021
Q1 | $408K | Buy |
20,176
+3,451
| +21% | +$69.8K | ﹤0.01% | 1580 |
|
|
2020
Q4 | $268K | Buy |
+16,725
| New | +$268K | ﹤0.01% | 1679 |
|
|
2020
Q3 | – | Sell |
-10,261
| Closed | -$73K | – | 1659 |
|
|
2020
Q2 | $73K | Buy |
+10,261
| New | +$73K | ﹤0.01% | 1606 |
|
|
2020
Q1 | – | Sell |
-10,042
| Closed | -$91K | – | 1301 |
|
|
2019
Q4 | $91K | Buy |
+10,042
| New | +$91K | ﹤0.01% | 1703 |
|
|
2018
Q4 | – | Sell |
-8,339
| Closed | -$237K | – | 1617 |
|
|
2018
Q3 | $237K | Buy |
+8,339
| New | +$237K | ﹤0.01% | 1492 |
|